185 related articles for article (PubMed ID: 29289933)
1. Study protocol for a multicentre, randomised, controlled trial to assess the effectiveness of antimicrobial central venous catheters versus ordinary central venous catheters at reducing catheter related infections in critically ill Chinese patients.
Wu M; Chen Y; Du B; Kang Y
BMJ Open; 2017 Dec; 7(12):e016564. PubMed ID: 29289933
[TBL] [Abstract][Full Text] [Related]
2. Catheter impregnation, coating or bonding for reducing central venous catheter-related infections in adults.
Lai NM; Chaiyakunapruk N; Lai NA; O'Riordan E; Pau WS; Saint S
Cochrane Database Syst Rev; 2016 Mar; 3(3):CD007878. PubMed ID: 26982376
[TBL] [Abstract][Full Text] [Related]
3. Antimicrobial-impregnated central venous catheters for preventing neonatal bloodstream infection: the PREVAIL RCT.
Gilbert R; Brown M; Faria R; Fraser C; Donohue C; Rainford N; Grosso A; Sinha AK; Dorling J; Gray J; Muller-Pebody B; Harron K; Moitt T; McGuire W; Bojke L; Gamble C; Oddie SJ
Health Technol Assess; 2020 Nov; 24(57):1-190. PubMed ID: 33174528
[TBL] [Abstract][Full Text] [Related]
4. Antimicrobial dressings for the prevention of catheter-related infections in newborn infants with central venous catheters.
Lai NM; Taylor JE; Tan K; Choo YM; Ahmad Kamar A; Muhamad NA
Cochrane Database Syst Rev; 2016 Mar; 3(3):CD011082. PubMed ID: 27007217
[TBL] [Abstract][Full Text] [Related]
5. Administration of taurolidine-citrate lock solution for prevention of central venous catheter infection in adult neutropenic haematological patients: a randomised, double-blinded, placebo-controlled trial (TAURCAT).
Gudiol C; Nicolae S; Royo-Cebrecos C; Aguilar-Guisado M; Montero I; Martín-Gandul C; Perayre M; Berbel D; Encuentra M; Arnan M; Cisneros-Herreros JM; Carratalà J
Trials; 2018 May; 19(1):264. PubMed ID: 29720244
[TBL] [Abstract][Full Text] [Related]
6. Comparative Efficacy of Antimicrobial Central Venous Catheters in Reducing Catheter-Related Bloodstream Infections in Adults: Abridged Cochrane Systematic Review and Network Meta-Analysis.
Chong HY; Lai NM; Apisarnthanarak A; Chaiyakunapruk N
Clin Infect Dis; 2017 May; 64(suppl_2):S131-S140. PubMed ID: 28475779
[TBL] [Abstract][Full Text] [Related]
7. Dressings and securement devices for central venous catheters (CVC).
Ullman AJ; Cooke ML; Mitchell M; Lin F; New K; Long DA; Mihala G; Rickard CM
Cochrane Database Syst Rev; 2015 Sep; 2015(9):CD010367. PubMed ID: 26358142
[TBL] [Abstract][Full Text] [Related]
8. The efficacy of a non-leaching antibacterial central venous catheter - a prospective, randomized, double-blind study.
Krikava I; Kolar M; Garajova B; Balik T; Sevcikova A; Roschke I; Sevcik P
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2020 Jun; 164(2):154-160. PubMed ID: 31142873
[TBL] [Abstract][Full Text] [Related]
9. Catheter impregnation, coating or bonding for reducing central venous catheter-related infections in adults.
Lai NM; Chaiyakunapruk N; Lai NA; O'Riordan E; Pau WS; Saint S
Cochrane Database Syst Rev; 2013 Jun; (6):CD007878. PubMed ID: 23740696
[TBL] [Abstract][Full Text] [Related]
10. Impregnated central venous catheters for prevention of bloodstream infection in children (the CATCH trial): a randomised controlled trial.
Gilbert RE; Mok Q; Dwan K; Harron K; Moitt T; Millar M; Ramnarayan P; Tibby SM; Hughes D; Gamble C;
Lancet; 2016 Apr; 387(10029):1732-42. PubMed ID: 26946925
[TBL] [Abstract][Full Text] [Related]
11. CATheter Infections in CHildren (CATCH): a randomised controlled trial and economic evaluation comparing impregnated and standard central venous catheters in children.
Harron K; Mok Q; Dwan K; Ridyard CH; Moitt T; Millar M; Ramnarayan P; Tibby SM; Muller-Pebody B; Hughes DA; Gamble C; Gilbert RE
Health Technol Assess; 2016 Mar; 20(18):vii-xxviii, 1-219. PubMed ID: 26935961
[TBL] [Abstract][Full Text] [Related]
12. Five-Lumen Antibiotic-Impregnated Femoral Central Venous Catheters in Severely Burned Patients: An Investigation of Device Utility and Catheter-Related Bloodstream Infection Rates.
Friedman BC; Mian MA; Mullins RF; Hassan Z; Shaver JR; Johnston KK
J Burn Care Res; 2015; 36(4):493-9. PubMed ID: 25407386
[TBL] [Abstract][Full Text] [Related]
13. Clinical epidemiology of central venous catheter-related bloodstream infections in an intensive care unit in China.
Peng S; Lu Y
J Crit Care; 2013 Jun; 28(3):277-83. PubMed ID: 23265289
[TBL] [Abstract][Full Text] [Related]
14. Reduction in Central Line-Associated Bloodstream Infections Correlated With the Introduction of a Novel Silver-Plated Dressing for Central Venous Catheters and Maintained for 6 Years.
Karlnoski R; Abboud EC; Thompson P; Oxner AZ; Sinnott JT; Marcet JE
J Intensive Care Med; 2019 Jul; 34(7):544-549. PubMed ID: 29216782
[TBL] [Abstract][Full Text] [Related]
15. Efficiency of chlorhexidine-silver sulfadiazine-impregnated venous catheters at subclavian sites.
Lorente L; Lecuona M; Jiménez A; Lorenzo L; Santacreu R; Ramos S; Hurtado E; Buitrago M; Mora ML
Am J Infect Control; 2015 Jul; 43(7):711-4. PubMed ID: 25934065
[TBL] [Abstract][Full Text] [Related]
16. Medical-grade honey does not reduce skin colonization at central venous catheter-insertion sites of critically ill patients: a randomized controlled trial.
Kwakman PH; Müller MC; Binnekade JM; van den Akker JP; de Borgie CA; Schultz MJ; Zaat SA
Crit Care; 2012 Oct; 16(5):R214. PubMed ID: 23111148
[TBL] [Abstract][Full Text] [Related]
17. Comparison of triple-lumen central venous catheters impregnated with silver nanoparticles (AgTive®) vs conventional catheters in intensive care unit patients.
Antonelli M; De Pascale G; Ranieri VM; Pelaia P; Tufano R; Piazza O; Zangrillo A; Ferrario A; De Gaetano A; Guaglianone E; Donelli G
J Hosp Infect; 2012 Oct; 82(2):101-7. PubMed ID: 22938728
[TBL] [Abstract][Full Text] [Related]
18. Prevention of hospital infections by intervention and training (PROHIBIT): results of a pan-European cluster-randomized multicentre study to reduce central venous catheter-related bloodstream infections.
van der Kooi T; Sax H; Pittet D; van Dissel J; van Benthem B; Walder B; Cartier V; Clack L; de Greeff S; Wolkewitz M; Hieke S; Boshuizen H; van de Kassteele J; Van den Abeele A; Boo TW; Diab-Elschahawi M; Dumpis U; Ghita C; FitzGerald S; Lejko T; Leleu K; Martinez MP; Paniara O; Patyi M; Schab P; Raglio A; Szilágyi E; Ziętkiewicz M; Wu AW; Grundmann H; Zingg W;
Intensive Care Med; 2018 Jan; 44(1):48-60. PubMed ID: 29248964
[TBL] [Abstract][Full Text] [Related]
19. Skin antisepsis for reducing central venous catheter-related infections.
Lai NM; Lai NA; O'Riordan E; Chaiyakunapruk N; Taylor JE; Tan K
Cochrane Database Syst Rev; 2016 Jul; 7(7):CD010140. PubMed ID: 27410189
[TBL] [Abstract][Full Text] [Related]
20. Control of Line Complications with KiteLock (CLiCK) in the critical care unit: study protocol for a multi-center, cluster-randomized, double-blinded, crossover trial investigating the effect of a novel locking fluid on central line complications in the critical care population.
Ornowska M; Wong H; Ouyang Y; Mitra A; White A; Willems S; Wittmann J; Reynolds S
Trials; 2022 Aug; 23(1):719. PubMed ID: 36042488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
